M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins et al., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, Science, vol.283, pp.1544-1552, 1999.

M. Elchebly, A. Cheng, and M. L. Tremblay, Modulation of insulin signaling by protein tyrosine phosphatases, J Mol Med, vol.78, pp.473-82, 2000.

A. Cheng, N. Dube, F. Gu, and M. L. Tremblay, Coordinated action of protein tyrosine phosphatases in insulin signal transduction, Eur J Biochem, vol.269, pp.1050-1059, 2002.

M. Delibegovic, K. K. Bence, N. Mody, E. G. Hong, H. J. Ko et al., Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B, Mol Cell Biol, vol.27, pp.7727-7761, 2007.

N. Dube and M. L. Tremblay, Beyond the metabolic function of PTP1B, Cell Cycle, vol.3, pp.550-553, 2004.

M. Vercauteren, R. E. Devaux, C. Dautreaux, B. Henry, J. P. Bauer et al., Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure, Circulation, vol.114, pp.2498-507, 2006.

R. Varin, P. Mulder, V. Richard, F. Tamion, C. Devaux et al., Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress, Circulation, vol.99, pp.2951-2958, 1999.

S. P. Jones, J. J. Greer, R. Van-haperen, D. J. Duncker, R. De-crom et al., Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice, Proc Natl Acad Sci U S A, vol.100, pp.4891-4897, 2003.

R. M. Witteles and M. B. Fowler, Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options, J Am Coll Cardiol, vol.51, pp.93-102, 2008.

J. W. Swan, C. Walton, I. F. Godsland, A. L. Clark, A. J. Coats et al., Insulin resistance in chronic heart failure, Eur Heart J, vol.15, pp.1528-1560, 1994.

C. Knauf, P. D. Cani, A. Ait-belgnaoui, A. Benani, C. Dray et al., Brain glucagonlike peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure, Endocrinology, vol.149, pp.4768-77, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00409099

C. Cabou, G. Campistron, N. Marsollier, C. Leloup, C. Cruciani-guglielmacci et al., Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity, Diabetes, vol.57, pp.2577-87, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00408890

F. Kim, B. Gallis, and M. A. Corson, TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells, Am J Physiol Cell Physiol, vol.280, pp.1057-65, 2001.

R. Varin, P. Mulder, F. Tamion, V. Richard, J. P. Henry et al., Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation, vol.102, pp.351-357, 2000.

J. J. Greer, A. K. Kakkar, J. W. Elrod, L. J. Watson, S. P. Jones et al., Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure, Am J Physiol Heart Circ Physiol, vol.291, pp.2743-51, 2006.

P. Balakumar, S. Kathuria, G. Taneja, S. Kalra, and N. Mahadevan, Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?, J Mol Cell Cardiol, vol.52, pp.83-92, 2012.

M. C. De-waard, R. Van-haperen, T. Soullie, D. Tempel, R. De-crom et al., Beneficial effects of exercise training after myocardial infarction require full eNOS expression, J Mol Cell Cardiol, vol.48, pp.1041-1050, 2010.

D. D. Belke, S. Betuing, M. J. Tuttle, C. Graveleau, M. E. Young et al., Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression, J Clin Invest, vol.109, pp.629-668, 2002.

P. Hu, D. Zhang, L. Swenson, G. Chakrabarti, E. D. Abel et al., Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload, Am J Physiol Heart Circ Physiol, vol.285, pp.1261-1270, 2003.

R. Liao, M. Jain, L. Cui, D. 'agostino, J. Aiello et al., Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice, Circulation, vol.106, pp.2125-2156, 2002.

F. G. Haj, B. Markova, L. D. Klaman, F. D. Bohmer, and B. G. Neel, Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B, J Biol Chem, vol.278, pp.739-783, 2003.

B. Kasibhatla, J. Wos, and K. G. Peters, Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes, Curr Opin Investig Drugs, vol.8, pp.805-818, 2007.

W. B. Kannel, M. Hjortland, and W. P. Castelli, Role of diabetes in congestive heart failure: the Framingham study, Am J Cardiol, vol.34, pp.29-34, 1974.

P. De-groote, N. Lamblin, F. Mouquet, D. Plichon, E. Mcfadden et al., Impact of diabetes mellitus on long-term survival in patients with congestive heart failure, Eur Heart J, vol.25, pp.656-62, 2004.